Calculation of Potency from a Single Assay Directions for calculating potency from the data of a single assay are given in the individual monographs. In those assays that specify graphical interpolation from dosageresponse curves but that meet the conditions for assay validity set forth herein, potency may be computed alternatively by the appropriate method in this section.
Planning the assay involves assigning to the Unknown an assumed potency, to permit administering it in dosages equivalent to those of the Standard. The closer the agreement between this original assumption and the result of the assay, the more precise is the calculated potency. The ratio of a given dose of the Standard, in µg or in USP Units, to the corresponding dose of the Unknown, measured as specified in the monograph, is designated uniformly by R. The logrelative potency in quantities assumed initially to equal those of the Standard is designated as M¢.
Ideally, M¢ should not differ significantly from zero. The logpotency is
or
Assay from Direct Determinations of the Threshold Dose—
Tubocurarine Chloride Injection and Metocurarine Iodide are assayed from the threshold dose that just produces a characteristic biological response. The ratio of the mean threshold dose for the Standard to that for the Unknown gives the potency directly. The threshold dose is determined twice in each animal, once with the Standard and once with the Unknown. Each dose is converted to its logarithm, the difference (x) between the two logdoses is determined for each animal, and potency is calculated from the average of these differences.
In the Bacterial Endotoxins Test 85, the geometric mean dilution endpoint for the Unknown corresponding to the geometric mean dilution endpoint for the Standard (multiplied by a dilution factor, where applicable) gives the concentration of endotoxin in the test material.
In these assays, the confidence interval depends upon the variability in the threshold dose.
Indirect Assays from the Relationship between the LogDose and the Response—
Generally, the threshold dose cannot be measured directly; therefore, potency is determined indirectly by comparing the responses following known doses of the Standard with the responses following one or more similar doses of the Unknown. Within a restricted dosage range, a suitable measure of the response usually can be plotted as a straight line against the logdose, a condition that simplifies the calculation of potency and its confidence interval. Both the slope and position of the logdose response relationship are determined in each assay by the use of two or more levels of the Standard, or, preferably, of both the Standard and the Unknown.
In the assay of Heparin Sodium, the interval between the dose at which clotting occurs and that which produces no clotting is so small that the dosageresponse curve is not determined explicitly. Moving averages are used instead to interpolate the logdose corresponding to 50% clotting for both the Standard and the Unknown, leading to the logpotency (see Calculation under Heparin Sodium). The precision of the potency is estimated from the agreement between independent assays of the same Unknown.
For a drug that is assayed biologically, the response should plot as a straight line against the logdose over an adequate range of doses. Where a preliminary test is required or the assay depends upon interpolation from a multidose Standard curve, plot on coordinate paper the mean response of the Standard at each dosage level on the ordinate against the logdose x on the abscissa. If the trend is basically linear over the required dosage range, the initial response unit may be used directly as y; if, instead, the trend is clearly curvilinear, a suitable transformation of each initial reading may bring linearity.
One possible transformation is to logarithms; another, in microbial tube assays, where y = (100 – % transmittance) does not plot linearly against the logdose x, is to probits. In this case, if absorbance cannot be read directly, the percent transmittance for each tube or test solution is first converted to absorbance, A = 2 log(% transmittance). Each absorbance value, in turn, is converted to % reduction in bacterial growth as
where Ac is the mean density for the control tubes (without antibiotic or with excess of vitamin) in the same set or tube rack. Percent reduction is then transformed to a probit (see Table 3) to obtain a new y for all later calculation. The probit transformation offers the advantage of extending the working range of linearity even where a portion of the dosageresponse relationship is nonlinear in the original units of percent transmittance, provided that the incubation period does not extend beyond the logarithmic phase of growth of the control tubes.
Table 3
The LD50 in the Safety test for Iron Dextran Injection is calculated with logdoses and probits. The four doses of the Injection, in mg of iron per kg of body weight, are transformed to x1 = 2.574, x2 = 2.699, x3 = 2.875, and x4 = 3.000. The probits corresponding to the number of deaths observed in each group of 10 mice are designated y1, y2, y3, and y4, respectively, and are given in Table 3 for mortalities from 10 to 90 percent. For observed deaths of 0 and 10 adjacent to doses giving an intermediate mortality, use the approximate probits 3.02 and 6.98, respectively; omit the end value (at x1 or x4) if not adjacent to an intermediate mortality. Since the information in a probit varies with its expectation, assign each probit an approximate relative weight w for computing the LD50 of the Injection, as shown in the accompanying table.
Calculate the weighted means
from the sum of the weights, Sw, of the four (or three) acceptable responses and the corresponding weighted sums of the logdoses, S(wx), and of the probits, S(wy). From the sums of the weighted products, S(wxy), and of the weighted squares, S(wx2), compute the slope b of the logdoseprobit line as
The LD50 for this safety test, in mg of iron per kg of body weight, is calculated as
In quantal assays not included in this Pharmacopeia, such as the mouse assay for insulin, the calculation with probits involves other adjustments that are omitted here.
When the mean response yt for each dose of Standard plots linearly against the logdose, and the k doses are spaced at equal intervals on the logarithmic scale, the predicted responses (YL and YH) at the extreme ends of the line of best fit can be computed directly with the coefficients x* in Table 4, which correspond to the k successive logdoses, as
where S stands uniformly for “the sum of” the values that follow it. When YL and YH are plotted against the low and high logdoses, XL and XH, respectively, they may be connected by a straight line with the slope
At any selected logdose x of Standard, the predicted response is
where x = Sx/k, and y = (YL + YH)/2, or, for predictions within a set, y is the mean response for the Standard within the set.
Table 4
When the logdose response relationship is linear, but the k doses (expressed in mL) are spaced substantially in an arithmetic sequence as in Table 5 (which refers to the microbial assays set forth under Antibiotics—Microbial Assays 81), the slope b of the straight line of best fit may be computed with the terms in Table 5 and the mean response at each dose yt, or Tt = fyt where the number of y's(f) is constant at each dose, as
The coefficients x1 are convenient multiples of the differences (x x) about the mean logdose x, and eb¢ i is the corresponding multiple of S(x x)2. The predicted response Y at a given logdose x may be computed by substitution of the assay slope b in Equation 5 and of the mean y either of all the responses on the Standard in the entire assay or of those for each set separately.
Table 5
potencies interpolated from a standard curve—
Where the logdose response curve of the Standard in a given assay is curvilinear and is fitted graphically to the plotted points, the amount of Standard that would be expected to produce each observed response y of an Unknown is estimated by interpolation from the curve and then adjusted for the known concentration of its test solution.
When the response to the Standard can be plotted linearly against the logdose, it is fitted numerically by a straight line, as described in the preceding section. For assays in randomized sets, a standard curve is computed with b for the assay and y for each set and the response yU in each tube of a given Unknown in that set is converted to an estimated logrelative potency,
where YS is the response predicted by the standard curve at the assumed logdose x of the Unknown. The average of the separate estimates from each of f sets, M¢ = SX/f, is the assayed logrelative potency of the Unknown.
Factorial Assays from the Response to Each Treatment—
When some function of the response can be plotted linearly against the logdose, the assayed potency is computed from the total response for each treatment, and its precision is measured in terms of confidence intervals. This requires that (1) in suitable units the response (y) depends linearly upon the logdose within the dosage range of the assay, and (2) the number ( f ) of responses be the same at each dosage level of both Standard and Unknown. The y's are totaled at each dosage level of each preparation. In different combinations, these totals, Tt, lead directly to the logrelative potency and to tests of assay validity. The factorial coefficients in Tables 6, 7, and 8 determine how they are combined. In a given row, each Tt is multiplied by the corresponding coefficient and the products summed to obtain Ti. The Ti's in the successive rows carry the same meaning in all assays.
Table 6
Ta in the first row measures the difference in the average response to the Standard and to the Unknown. Tb in the second row leads directly to the combined slope of the dosageresponse curves for both Standard and Unknown. The third to the fifth rows (ab, q, and aq) provide tests for the validity of an assay, as described in a later section. From the totals Ta and Tb, compute the logrelative potency of the Unknown, before adjustment for its assumed potency, as
where i is the interval in logarithms between successive logdoses of both the Standard and the Unknown, and the constant c is given separately at the bottom of each table. Each M¢ is corrected to its logpotency M by Equation 2.
When doses are spaced unequally on a log scale, as in Table 8, use instead the constant ci at the bottom of the table.
Table 7
Table 8
In a fully balanced assay, such as the assay for corticotropin, compute M¢ with the coefficients in Table 6. If one preparation has one less dose than the other but the successive logdoses of both Standard and Unknown differ by a constant interval i, use the factorial coefficients in Table 7, correcting for the actual difference between the observed mean logdoses, xS and xU, by computing
In assays where the successive doses are not spaced at equal logintervals, the logrelative potency of a single Unknown may be computed by Equation 8 with the factorial coefficients and ci in Table 8.
In an assay of two or more Unknowns against a common Standard, all with dosageresponse lines that are parallel within the experimental error, each logrelative potency may be computed with the same assay slope as follows. For each preparation, determine the slope factor Tb¢ = S(x1Tt) or S(x1y), where the values of x1 are the factorial coefficients for the Standard in the appropriate row b of Table 6 or 8. The logrelative potency of each Unknown is
where h¢ is the number of values of Tb¢ summed in the denominator.
Assays from Differences in Response—
When doses of the Standard and Unknown are paired and the difference in response is computed for each pair, these differences are not affected by variations in the average sensitivity of the paired readings. The paired 2dose insulin assay corresponds to the first design in Table 6, and requires four equal groups of rabbits each injected twice (see Insulin Assays 121). The difference (y) in the blood sugar response of each rabbit to the two treatments leads to the logrelative potency M¢ (see the first two paragraphs of the section, Calculation of Potency from a Single Assay). The Vasopressin Injection assay follows a similar design, substituting two or more randomized sets of four successive pairs of injections into rats for the four treatment groups of rabbits in the insulin assay.
Oxytocin Injection is assayed from blood pressure changes in a single test animal following alternating injections of a single dose of Standard and of one of two doses of the Unknown. The calculation of potency from the differences in the response of the Unknown and to the average of the two adjacent responses to the Standard is equivalent to the first design in Table 7 with S and U reversed, where i is the loginterval between the two dosage levels of the Unknown.
